About HGHFX
The Hartford Healthcare Fund Class F is an open-end mutual fund focused on delivering long-term capital appreciation by investing primarily in the global healthcare sector. Managed by an experienced team from Wellington Management, the fund allocates at least 80% of its assets to equity securities of companies engaged in healthcare-related industries, encompassing pharmaceuticals, biotechnology, medical technology, healthcare services, and emerging healthcare subsectors. The portfolio is broadly diversified, typically holding around 100 stocks, with substantial exposure to large-cap healthcare firms while also investing in mid- and small-cap companies to capture sector innovation and growth opportunities. Notable portfolio holdings include leading names such as Eli Lilly & Co., UnitedHealth Group, and Merck & Co. The fund emphasizes U.S. equities but also maintains exposure to international healthcare companies, reflecting the sector’s global scope. With annual operating expenses around 0.91% and an active share of approximately 44%, the Hartford Healthcare Fund Class F plays a significant role for investors seeking targeted exposure to healthcare markets, leveraging sector expertise and active management to capitalize on trends and advancements within the industry.
Fund Family Hartford Mutual Funds
Category Health
Performance Rating Average
Risk Rating Below Average
Stock Exchange NASDAQ
Ticker Symbol HGHFX
Share Class Class F
Index S&P Composite 1500 Health Care TR
HGHFX had a total return of 27.54% in the past year, including dividends. Since the fund's
inception, the average annual return has been 9.32%.
